Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$600M |
| 2 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$353M |
| 3 |
Energy Transfer Partners
ET
|
+$350M |
| 4 |
TWX
Time Warner Inc
TWX
|
+$332M |
| 5 |
Financial Select Sector SPDR Fund
XLF
|
+$317M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.19B |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$470M |
| 3 |
KLA
KLAC
|
+$282M |
| 4 |
ITC
ITC HOLDINGS CORP
ITC
|
+$270M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$264M |
Sector Composition
| 1 | Financials | 11.02% |
| 2 | Technology | 9.18% |
| 3 | Energy | 8.61% |
| 4 | Healthcare | 6.6% |
| 5 | Consumer Discretionary | 5.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3676
ReposiTrak
TRAK
$311M
| $138K | ﹤0.01% |
10,909
+9,841
| +921% | +$124K |
|
|
FCRD
3677
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $138K | ﹤0.01% |
13,787
-4,080
| -23% | -$40.8K |
|
|
MIE
3678
DELISTED
COHEN & STEERS MLP INCOME AND ENERGY OPPORTUNITY FUND, INC.
MIE
| $138K | ﹤0.01% |
12,702
-21,503
| -63% | -$234K |
|
|
NVIV
3679
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $138K | ﹤0.01% |
+2
| New | +$138K |
|
3680
Santander
BSBR
$40.1B
| $137K | ﹤0.01% |
16,040
+3,843
| +32% | +$32.8K |
|
|
HIVE
3681
DELISTED
AEROHIVE NETWORKS, INC.
HIVE
| $137K | ﹤0.01% |
24,113
+22,147
| +1,127% | +$126K |
|
3682
AngloGold Ashanti
AU
$33.5B
| $136K | ﹤0.01% |
12,945
-109,145
| -89% | -$1.15M |
|
3683
First Trust Technology AlphaDEX Fund
FXL
$1.41B
| $136K | ﹤0.01% |
3,593
-30
| -0.8% | -$1.14K |
|
|
GMRE
3684
Global Medical REIT
GMRE
$512M
| $136K | ﹤0.01% |
15,279
+14,043
| +1,136% | +$125K |
|
3685
Nature's Sunshine
NATR
$299M
| $136K | ﹤0.01% |
9,047
+8,358
| +1,213% | +$126K |
|
3686
Gulf Island Fabrication
GIFI
$122M
| $135K | ﹤0.01% |
11,370
+2,483
| +28% | +$29.5K |
|
3687
Invesco Biotechnology & Genome ETF
PBE
$224M
| $135K | ﹤0.01% |
3,478
-1,202
| -26% | -$46.7K |
|
3688
Patterson-UTI
PTEN
$2.13B
| $135K | ﹤0.01% |
5,040
-119,728
| -96% | -$3.21M |
|
3689
Martin Midstream Partners
MMLP
$119M
| $134K | ﹤0.01% |
7,299
-10,506
| -59% | -$193K |
|
3690
Wipro
WIT
$29B
| $134K | ﹤0.01% |
73,771
-5,962
| -7% | -$10.8K |
|
|
EFR
3691
Eaton Vance Senior Floating-Rate Fund
EFR
$344M
| $133K | ﹤0.01% |
9,006
| – | – |
|
|
JKS
3692
JinkoSolar
JKS
$1.3B
| $133K | ﹤0.01% |
8,723
+3,730
| +75% | +$56.9K |
|
|
MYOV
3693
DELISTED
Myovant Sciences Ltd.
MYOV
| $133K | ﹤0.01% |
+10,701
| New | +$133K |
|
3694
Teucrium Corn Fund
CORN
$49.7M
| $132K | ﹤0.01% |
7,075
-18,825
| -73% | -$351K |
|
3695
Esperion Therapeutics
ESPR
$573M
| $132K | ﹤0.01% |
10,530
-3,992
| -27% | -$50K |
|
3696
Varonis Systems
VRNS
$6.3B
| $132K | ﹤0.01% |
14,829
+11,964
| +418% | +$106K |
|
|
MODN
3697
DELISTED
MODEL N, INC.
MODN
| $132K | ﹤0.01% |
15,004
+12,706
| +553% | +$112K |
|
|
TAHO
3698
DELISTED
Tahoe Resources Inc
TAHO
| $132K | ﹤0.01% |
14,068
+6,757
| +92% | +$63.4K |
|
3699
Oxford Square Capital
OXSQ
$170M
| $131K | ﹤0.01% |
19,836
-7,288
| -27% | -$48.1K |
|
|
KERX
3700
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $131K | ﹤0.01% |
22,441
+491
| +2% | +$2.87K |
|